It is common practice for orally administered medications to adhere to the rule of three. This guideline dictates that for a drug to be considered orally active, it should have a molecular weight that is less than 300. Additionally, the c LogP value of the drug should not exceed 3, and the hydrogen bond donor count and hydrogen bond acceptor count should each be equal to or less than 3. These specifications are widely recognized within the pharmacological industry as critical factors for the successful development of orally active drugs.Can you confirm if the characteristics of the given molecule align with the criteria of the rule of three guidelines?